Additionally, as an HDAC inhibitor, butyrate establishes an anti-inflammatory environment in both the gut and tumor microenvironment by inhibiting HDAC activity in macrophages and dendritic cells (DCs) [932,933]. This evidence concerns the gene HDAC9 and neoplasm.